Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2010
04/27/2010US7704995 Protein kinase modulators and methods of use
04/27/2010US7704994 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3- pyridinyl}-2-pyrrolidinone and salts; histamine H3 antagonists; Alzheimer's disease; schizophrena; antiepileptic agents; analgesics; neuropathic pain; Parkinson's disease; attention deficit disorder
04/27/2010CA2563042C 4-2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
04/27/2010CA2495880C Pyrimidine derivatives and their use as cb2 modulators
04/27/2010CA2493667C Vanilloid receptor ligands and their use in treatments
04/27/2010CA2449180C Viral polymerase inhibitors
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/27/2010CA2408649C Piperazinedione compounds
04/27/2010CA2394848C 3-(4,5-dihydroisoxazole-5-yl)benzoylpyrazole
04/22/2010WO2010045580A1 Sphingosine-1-phosphate receptor antagonists
04/22/2010WO2010045575A2 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders
04/22/2010WO2010045188A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
04/22/2010WO2010044410A1 Biaryl isonicotinic acid derivative and medical application of same
04/22/2010WO2010044403A1 5-membered heteroaryl derivative and use thereof for medical purposes
04/22/2010WO2010043315A1 Pesticidal (hetero) arylpyrrolidines
04/22/2010WO2010043052A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/22/2010WO2010043010A1 N-acyl hydrazine derivatives, method for producing n-acyl hydrazine compounds, pharmaceutical compositions containing same, uses thereof and methods for treatment
04/22/2010WO2010012442A3 Insecticidal benzenedicarboxamide derivative
04/22/2010WO2009068468A3 Pyridine compounds
04/22/2010US20100099883 Process for the preparation of compounds useful as inhibitors of sglt
04/22/2010US20100099752 Pharmaceutical composition containing bicyclic type compounds
04/22/2010US20100099689 Methods of modulating ppar gamma-type receptors
04/22/2010US20100098653 Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
04/22/2010DE102009049696A1 Verbindung mit einer Salzgruppe und einer p-Halbleitergruppe und deren Verwendung in Solarzellen Compound with a salt group, and a p-type semiconductor group and their use in solar cells
04/22/2010CA2741060A1 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders
04/22/2010CA2740853A1 Process for the preparation of compounds useful as inhibitors of sglt
04/22/2010CA2740783A1 Sphingosine-1-phosphate receptor antagonists
04/22/2010CA2740608A1 Pesticidal (hetero) arylpyrrolidines
04/22/2010CA2739466A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/22/2010CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
04/21/2010EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors
04/21/2010EP2177518A1 Organic compounds
04/21/2010EP2177516A1 Aromatic amine derivative and organic electroluminescent device using the same
04/21/2010EP2177512A1 Inhibitor of binding of s1p1
04/21/2010EP2177511A2 Process for preparing 3,6-disubstituted azabicyclo derivatives
04/21/2010EP2176255A1 Andrographolide derivatives and use thereof in manufacture of medicaments
04/21/2010EP2176254A1 Dna pk inhibitors
04/21/2010EP2176251A2 5-pyridinone substituted indazoles
04/21/2010EP2176223A1 Malonamide derivatives with antithrombotic activity
04/21/2010EP1761494B1 Chemical compounds i
04/21/2010EP1620082B1 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
04/21/2010EP1610780B1 Cyclic protein tyrosine kinase inhibitors
04/21/2010EP1258252B1 Integrin expression inhibitors
04/21/2010CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors
04/21/2010CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes
04/21/2010CN101696221A Substituted isoxazoles as fungicides
04/20/2010US7700787 Small molecular thiophene compound
04/20/2010US7700771 antiinflammatory agents; antiarthritic agents
04/20/2010US7700765 DNA minor groove binding compounds
04/20/2010US7700643 for use in charge injection layer, planarizing layer, antistatic film or conducting substrate or pattern for electronic applications or flat panel displays; semiconductors; electrooptics
04/20/2010US7700634 (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor
04/20/2010US7700630 3-Quinolin-2-ylmethylene-3,4,5,6-terahydro[2,3']bipyridinyl; for therapy and prophylaxis of psychotic diseases, neurodegenerative diseases involving a dysfunction of the cholinergic system
04/20/2010US7700628 Aromatic ether derivatives useful as thrombin inhibitors
04/20/2010US7700627 5-{(R)-1-[4-(1-Hydroxyhexyl)phenyl]-6-oxopiperidin-2-ylmethoxymethyl}-thiophene-2-carboxylic acid
04/20/2010CA2510540C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
04/20/2010CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors
04/15/2010WO2010042674A1 Pyrrolone melanin concentrating hormone receptor-1 antagonists
04/15/2010WO2010042473A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010041575A1 Fullerene derivative, composition, and organic photoelectric conversion element
04/15/2010WO2010041162A1 Tetrahydrofuranyl sulfonamides for use as ampa modulators in the treatment of cns disorders
04/15/2010WO2010041054A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
04/15/2010WO2010022033A3 Therapeutic substituted pyrroles
04/15/2010WO2009024341A8 Condensed anthran i lami de derivatives as insectisides
04/15/2010US20100094016 Thiazoline acid derivatives
04/15/2010US20100094014 Excitatory amino acid receptor antagonists
04/15/2010US20100093802 Ccr9 inhibitors and methods of use thereof
04/15/2010US20100093775 Compounds and methods for the treatment or prevention of flavivirus infections
04/15/2010US20100093744 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes
04/15/2010US20100093733 Amide and urea derivatives for the treatment of metabolic diseases
04/15/2010US20100093729 Substituted gamma lactams as therapeutic agents
04/15/2010US20100093707 Acid amide derivatives, process for their production and pesticides containing them
04/15/2010US20100093702 METHYLENE AMINES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093693 Modulators of cellular adhesion
04/15/2010CA2739559A1 Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof
04/15/2010CA2739527A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
04/14/2010EP2174939A1 Pyranones useful as ATM inhibitors
04/14/2010EP2173727A1 Novel herbicides
04/14/2010EP2173716A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
04/14/2010EP2173715A2 Use of piperidine derivatives as agonists of chemokine receptor activity
04/14/2010EP1858890B1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010EP1656141B1 Treatment for alzheimer s disease and related conditions
04/14/2010EP1599201B1 Selective non-steroidal glucocorticoid receptor modulators
04/14/2010EP1400515B1 Cyclic diamine compound having five-membered cyclic group
04/14/2010EP1335901B1 Pharmaceutically active sulfanilide derivatives
04/14/2010CN101693708A Azasugar compound containing aryl and preparation process and application thereof
04/14/2010CN101693697A Pyrizdazine derivatives and their use as therapeutic agents
04/14/2010CN101693695A Pyrimidine derivatives and methods of treatment related to the use thereof
04/13/2010US7696352 Factor Xa inhibitors
04/13/2010US7696257 Oxime ester compound and photopolymerization initiator containing such compound
04/13/2010US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin
04/13/2010US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome
04/13/2010US7696230 1-(aminomethyl)cyclohexan acetic acid 2-methoxy-4-[(1E)-3-[4-(nitrooxy) butoxy]-3-oxy-1-propenyl]phenyl hydrochloride ester ; reduced side effects; neuropathic pain
04/13/2010US7696226 HIV protease inhibiting compounds
04/13/2010US7696225 (2-carboxamido)(3-Amino) thiophene compounds
04/13/2010US7696221 Thienoisoquinoline-phenylsulfonamides and their use as ER-NFκB inhibitors
04/13/2010US7696216 Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives
04/13/2010US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors